-
May 07 |
Diagnostics World | In oncology, it is well appreciated that time is life. Diagnostics are therefore valuable not just to determine the disease state of patients but how best to treat them, says Jane Li, senior director of oncology, pharma, and CRO partnerships related to clinical sequencing at Thermo Fisher Scientific.
More
-
May 02 |
Diagnostics World | A much-anticipated rule to regulate laboratory developed tests (LDTs) as medical devices has arrived, with significant implications for the diagnostic industry and patient care. Here’s a closer look at the historical context underlying the new rule, the debate leading up to this moment, recent updates, and the road ahead.
More
-
May 01 |
Diagnostics World | Significant evidence now exists implicating the Epstein-Barr virus (EBV) as a causal factor in the development of multiple sclerosis (MS), making treatment of the virus a priority. To that end, research scientists at Trinity College Dublin have developed a blood test to measure the immune response to EBV that could be used as an outcome measure in future clinical trials in people with established MS.
More
-
Apr 30 |
Diagnostics World | Researchers at the University of Chicago have succeeded in creating a digital twin of the gut microbiome of premature infants that reliably models the many interactions taking place between quickly changing bacterial inhabitants. The so-called “Q-net” model, created with generative artificial intelligence (AI), was used to make predictions about which infants were going to have neurodevelopmental deficits using head circumference as the proxy.
More
-
Apr 25 |
Diagnostics World | Roche will distribute Prenosis’s Sepsis ImmunoScore, an artificial intelligence/machine learning software as a medical device to guide rapid diagnosis of sepsis and prediction of adverse outcomes; PathAI announced a strategic partnership with Google Cloud at Bio-IT World Conference & Expo to help biopharma companies and anatomic pathology labs accelerate the adoption of AI and digital pathology; more.
More
-
Apr 24 |
Diagnostics World | Asher Therapeutics will advance the clinical development of its lead program, AB248, a novel CD8+ T cell selective IL-2, generated by fusing a reduced potency IL-2 mutein to an anti-CD8β antibody; Kryptos Biotechnologies will further develop Kryptos’s flagship point-of-care molecular diagnostics system Kuick and advance the clinical study of the respiratory combo tests; DeepCure plans to advance its generative AI and physics-based engine to innovate the discovery of small molecule therapies for challenging targets; more.
More
-
Apr 18 |
Diagnostics World | Researchers in Denmark have devised a blood-based diagnostic technique that can detect even trace amounts of an aggregated protein indicative of Alzheimer’s disease before any disease-related changes show up on a PET scan, one of the traditional testing methods. The same technology can be used for developing new therapies by revealing what part of the innate immune system is engaged in the fight.
More
-
Apr 17 |
Diagnostics World | Minimal residual disease testing (MRD) has been gaining ground in diagnostics, and a panel took on the topic at the Precision Medicine TriCon late last month.
More
-
Apr 16 |
Diagnostics World | At the Precision Med TriConference 2024, Illumina Ventures partner Mara Aspinall sat with Eric Topol, endowed chair and executive VP and professor at Scripps Translational Science Institute, in a fireside chat to discuss precision medicine and artificial intelligence (AI). With three published books and more than 1,200 peer reviewed publications, Topol is one of the industry’s leading minds on digital medicine, and from his perspective, AI needs to be adapted sooner.
More
-
Apr 11 |
Diagnostics World | As the body’s stress hormone, cortisol influences several diseases, from chronic illnesses, such as diabetes and cancer; to mental illnesses, such as depression; to neurological diseases, such as Alzheimer’s disease. Researchers at Aarhus University have discovered a breakthrough method to measure cortisol in an efficient, faster way.
More
-
Sep 25 |
PRINCETON, NJ - Sep 25, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced that the US Food and Drug Administration (FDA) has renewed its legacy licenses for Synchrogenixs electronic Common Technical Document (eCTD) review software, GlobalSubmit REVIEW and GlobalSubmit VALIDATE for another year
More
-
Sep 24 |
PHILADELPHIA, PA, UNITED STATES - Sep 24, 2019 - Proscia, a leading provider of digital pathology software, has been granted U.S. Patent No. 10,346,980 by the United States Patent and Trademark Office (USPTO)
More
-
Sep 24 |
ROYSTON, UK - Sep 24, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has joined UK Medicines Discovery Catapults Discovery Services Platform, partnering with other best-in-class service providers to help improve preclinical drug discovery success rates
More
-
Sep 17 |
, UK - Sep 17, 2019 - QuantuMDx Group Limited, a UK-based life sciences company developing transformational point of care diagnostics, is pleased to announce Neil Butler has joined its Board as an Independent Non-Executive Director
More
-
Sep 17 |
PRINCETON, NJ - Sep 17, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division is pleased to announce that enrollment in WCG KMR Groups 2019 Clinical Trial Cost Study is now open
More
-
Sep 17 |
PRINCETON, NJ - Sep 17, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Hasharc, its decentralized application (DApp) for healthcare, built in conjunction with the Hedera public Distributed Ledger Technology (DLT)
More
-
Sep 12 |
HONOLULU, HI, UNITED STATES - Sep 13, 2019 - Honolulu, HI (September 13, 2019) - A recently released workforce supply and demand study conducted by the Healthcare Association of Hawaii (HAH) reveals a need for phlebotomists in the state
More
-
Sep 12 |
CAMBRIDGE, MA - Sep 12, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced the launch of a healthcare industry open source initiative for wearable sensor algorithms
More
-
Sep 12 |
PRINCETON, NJ - Sep 12, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Phoenix® 8
More
-
Sep 11 |
ROYAL OAK, MI, UNITED STATES - Sep 11, 2019 - OncoCell MDx, Inc., a pan-disease immunogenomics platform company developing novel noninvasive blood-based tests to optimize patient care, today announced it has raised $22
More
View more articles